Sight Sciences, Inc.
SGHT
$8.36
-$0.03-0.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.91M | 19.56M | 17.51M | 19.07M | 20.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.91M | 19.56M | 17.51M | 19.07M | 20.16M |
| Cost of Revenue | 2.71M | 2.98M | 2.41M | 2.51M | 3.25M |
| Gross Profit | 17.20M | 16.59M | 15.09M | 16.56M | 16.91M |
| SG&A Expenses | 21.75M | 23.87M | 24.52M | 24.20M | 23.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.81M | 31.23M | 31.37M | 31.00M | 31.39M |
| Operating Income | -7.91M | -11.67M | -13.86M | -11.93M | -11.23M |
| Income Before Tax | -8.25M | -11.90M | -14.11M | -11.81M | -10.90M |
| Income Tax Expenses | -79.00K | 40.00K | 41.00K | 38.00K | 166.00K |
| Earnings from Continuing Operations | -8.17M | -11.94M | -14.15M | -11.85M | -11.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.17M | -11.94M | -14.15M | -11.85M | -11.07M |
| EBIT | -7.91M | -11.67M | -13.86M | -11.93M | -11.23M |
| EBITDA | -7.80M | -11.54M | -13.71M | -11.75M | -11.07M |
| EPS Basic | -0.16 | -0.23 | -0.28 | -0.23 | -0.22 |
| Normalized Basic EPS | -0.10 | -0.14 | -0.17 | -0.15 | -0.14 |
| EPS Diluted | -0.16 | -0.23 | -0.28 | -0.23 | -0.22 |
| Normalized Diluted EPS | -0.10 | -0.14 | -0.17 | -0.15 | -0.14 |
| Average Basic Shares Outstanding | 52.38M | 51.82M | 51.29M | 50.80M | 50.34M |
| Average Diluted Shares Outstanding | 52.38M | 51.82M | 51.29M | 50.80M | 50.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |